Pharos Capital Invests in Renal Care 360º, Capitalizes New Chronic Kidney Care Management Platform

Dallas, TX and Nashville, TN — September 12, 2022 — Pharos Capital Group, LLC (“Pharos”), a middle-market private equity firm based in Dallas and Nashville, announced a significant investment in Renal Care 360° (“Renal Care 360°” or the “Company”), a comprehensive nephrology practice and chronic care management company founded by renal care entrepreneur Joe Cashia.

Renal Care 360° partners with health systems, physician groups, and local communities to provide enhanced community healthcare management services, with a primary focus on patients in underserved rural communities.

Pharos’ investment, along with additional equity investment from the Company’s founding shareholders, will support the continued growth of the Company’s RC360° Connected Care Program, geographic expansion through acquisitions, and the development of value-based care programs. Terms of the transaction were not disclosed.

Renal Care 360° has developed a care model centered on the early detection of unidentified chronic conditions using proprietary data analytics. Once medical conditions are identified, the Company offers early interventions through affiliated physician practices, including personalized education, real-time engagement, local and virtual clinic options, and dedicated care coordination.

The Company’s approach is designed to slow disease progression and improve outcomes for patients with chronic kidney disease (“CKD”), end-stage kidney disease (“ESKD”), and other co-morbidities. Renal Care 360° is also working to raise awareness and improve education around kidney disease in areas most affected by inequities in access to care, enabling health system and physician group partners to proactively engage and care for their patients.

Jim Phillips, Partner at Pharos, said Renal Care 360°’s use of machine learning to identify vulnerable CKD and ESKD patients early and provide comprehensive, compassionate care represents a uniquely impactful model. He noted that the Company’s specialized approach helps slow disease progression, prevent unnecessary hospital admissions, improve patient experiences, and support better outcomes. He also said Pharos is pleased to partner with a management team deeply committed to kidney care, physician practice management, home health, population health, and improving the lives of patients who may otherwise fall through the cracks.

Renal Care 360° founder Joe Cashia will continue to lead the Company as Chairman and CEO. Mr. Cashia is a 35-plus-year veteran of the healthcare industry with deep experience across the kidney care continuum. He has partnered with physicians and hospitals across the country and has created, acquired, and managed more than 1,000 healthcare centers.

Mr. Cashia previously served as CEO of National Renal Alliance, Vivere Health, and Ascend Health Care Services, and has held various Board roles. His experience includes scaling complex healthcare service organizations and partnering with physician leaders and clinicians to drive value-based care initiatives and improve patient outcomes.

Mr. Cashia said Pharos’ healthcare experience and commitment to bridging inequities in care will be valuable as Renal Care 360° expands its clinic footprint, scales chronic care management infrastructure, and works with health systems and payors to align incentives around patient outcomes and cost savings.

About Renal Care 360°

Renal Care 360° is a comprehensive nephrology practice and chronic care management company partnering with health systems, physician groups, and local communities to provide enhanced community healthcare management services.

Renal Care 360°’s Connected Care Program partners with PCPs, nephrologists, and other physician groups to augment existing services by providing patients with customized care coordination and education programs based on their health needs.

In addition to contracted chronic care management services, Renal Care 360° intends to acquire nephrology practices that share its passion for transforming kidney care through early detection and deep patient engagement with comprehensive care management.

Renal Care 360° Business Development Contact

Molly Braun
985-264-4074
mbraun@renalcare360.com

About Pharos Capital Group

Based in Dallas and Nashville, Pharos Capital Group is a physician-founded investment firm focused on growing healthcare companies that aim to lower the total cost of care, improve patient outcomes, and reduce healthcare inequalities in underserved markets, especially within urban and rural communities.

Since inception, Pharos has invested in 58 companies and had over $1.2 billion of private equity assets under management as of June 30, 2022.

Pharos typically invests $25 million to $50 million in rapidly growing middle-market companies seeking later-stage funding for internal growth, acquisitions, leveraged buyouts, management buyouts, or recapitalizations across healthcare sectors.

For business development opportunities with Pharos Capital Group, please contact Adam Persiani at 214-740-7003 or apersiani@pharosfunds.com.

Media Contact

Jennifer Hurson
Lambert
845-507-0571
jhurson@lambert.com

‍